PODNL1

gene
On this page

Also known as FLJ23447SLRR5B

Summary

PODNL1 (podocan like 1, HGNC:26275) is a protein-coding gene on chromosome 19p13.12, encoding Podocan-like protein 1 (Q6PEZ8).

An extracellular matrix structural constituent. Is active in collagen-containing extracellular matrix.

Source: NCBI Gene 79883 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 130 total
  • MANE Select transcript: NM_001370095

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26275
Approved symbolPODNL1
Namepodocan like 1
Location19p13.12
Locus typegene with protein product
StatusApproved
AliasesFLJ23447, SLRR5B
Ensembl geneENSG00000132000
Ensembl biotypeprotein_coding
OMIM621043
Entrez79883

Gene structure

Transcript identifiers

Ensembl transcripts: 17 — 15 protein_coding, 2 protein_coding_CDS_not_defined

ENST00000254320, ENST00000339560, ENST00000538371, ENST00000538517, ENST00000585607, ENST00000586075, ENST00000587288, ENST00000587458, ENST00000587954, ENST00000588317, ENST00000588764, ENST00000588872, ENST00000591353, ENST00000886044, ENST00000886045, ENST00000946318, ENST00000946319

RefSeq mRNA: 5 — MANE Select: NM_001370095 NM_001146254, NM_001146255, NM_001370095, NM_001411137, NM_024825

CCDS: CCDS12300, CCDS54225, CCDS54226, CCDS92538, CCDS92539

Canonical transcript exons

ENST00000588872 — 10 exons

ExonStartEnd
ENSE000006853021393387813933993
ENSE000013850931393598013936044
ENSE000013857241393425413934410
ENSE000027700031393196413932112
ENSE000028397461393279813933455
ENSE000029009101393118713931887
ENSE000034617621393636713936460
ENSE000034869661393778513938006
ENSE000035839071393572113935830
ENSE000038160851393817913938417

Expression profiles

Bgee: expression breadth ubiquitous, 132 present calls, max score 85.72.

FANTOM5 (CAGE): breadth broad, TPM avg 2.4287 / max 42.0770, expressed in 888 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
1795801.1186470
1795790.8107340
1795770.2517125
1795760.2476135

Top tissues by expression

135 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
tibial nerveUBERON:000132385.72gold quality
right coronary arteryUBERON:000162584.54gold quality
apex of heartUBERON:000209884.09gold quality
lower esophagus mucosaUBERON:003583483.17gold quality
placentaUBERON:000198783.13gold quality
ascending aortaUBERON:000149682.70gold quality
thoracic aortaUBERON:000151582.25gold quality
left coronary arteryUBERON:000162681.65gold quality
sural nerveUBERON:001548880.33gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047380.09gold quality
skin of legUBERON:000151179.99gold quality
zone of skinUBERON:000001479.58gold quality
skin of abdomenUBERON:000141679.27gold quality
stromal cell of endometriumCL:000225578.93gold quality
descending thoracic aortaUBERON:000234578.90gold quality
mucosa of transverse colonUBERON:000499178.67gold quality
vaginaUBERON:000099678.06gold quality
popliteal arteryUBERON:000225077.52gold quality
tibial arteryUBERON:000761077.50gold quality
esophagus mucosaUBERON:000246977.07gold quality
hypothalamusUBERON:000189876.44gold quality
cerebellar hemisphereUBERON:000224573.39gold quality
cerebellumUBERON:000203773.29gold quality
cerebellar cortexUBERON:000212973.27gold quality
right hemisphere of cerebellumUBERON:001489073.14gold quality
substantia nigraUBERON:000203872.15gold quality
olfactory segment of nasal mucosaUBERON:000538672.08gold quality
minor salivary glandUBERON:000183071.33gold quality
endocervixUBERON:000045870.57gold quality
adenohypophysisUBERON:000219670.56gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-GEOD-110499no8.81
E-ANND-3no2.39

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

37 targeting PODNL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4425100.0067.591049
HSA-MIR-6876-5P100.0067.682126
HSA-MIR-520G-5P99.9966.76658
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-6825-5P99.9669.813431
HSA-MIR-430799.8270.453374
HSA-MIR-6752-3P99.7266.711587
HSA-MIR-378G99.7164.901106
HSA-MIR-320299.6667.702737
HSA-MIR-1252-3P99.5567.712862
HSA-MIR-57899.4668.361787
HSA-MIR-807799.1766.67862
HSA-MIR-7160-5P99.1167.172207
HSA-MIR-7151-3P99.0469.722370
HSA-MIR-445198.8268.171455
HSA-MIR-5006-5P98.7966.921246
HSA-MIR-6840-3P98.6865.951923
HSA-MIR-557298.5565.84970
HSA-MIR-7114-3P98.4266.53569
HSA-MIR-3187-5P98.3665.741776
HSA-MIR-6773-3P98.1765.511213
HSA-MIR-1285-3P97.7267.021932
HSA-MIR-5189-5P97.7266.961814
HSA-MIR-6812-5P97.5665.391059
HSA-MIR-61297.2665.951597
HSA-MIR-686097.2166.311656
HSA-MIR-428697.2064.371587
HSA-MIR-431397.1863.15420
HSA-MIR-10398-5P97.1264.941051
HSA-MIR-448696.9660.61931

Literature-anchored findings (GeneRIF, showing 1)

  • PODNL1 Methylation Serves as a Prognostic Biomarker and Associates with Immune Cell Infiltration and Immune Checkpoint Blockade Response in Lower-Grade Glioma. (PMID:34830454)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusPodnl1ENSMUSG00000012889
rattus_norvegicusPodnl1ENSRNOG00000006741

Paralogs (22): DCN (ENSG00000011465), RTN4R (ENSG00000040608), ASPN (ENSG00000106819), FLRT3 (ENSG00000125848), FLRT1 (ENSG00000126500), LRRC4 (ENSG00000128594), LRRC4B (ENSG00000131409), LRTM1 (ENSG00000144771), LRRC4C (ENSG00000148948), LRRTM1 (ENSG00000162951), LRRC15 (ENSG00000172061), PODN (ENSG00000174348), LRRTM4 (ENSG00000176204), BGN (ENSG00000182492), LRRC19 (ENSG00000184434), FLRT2 (ENSG00000185070), GP1BA (ENSG00000185245), RTN4RL1 (ENSG00000185924), RTN4RL2 (ENSG00000186907), NYX (ENSG00000188937), LRRC66 (ENSG00000188993), LRRTM3 (ENSG00000198739)

Protein

Protein identifiers

Podocan-like protein 1Q6PEZ8 (reviewed: Q6PEZ8)

All UniProt accessions (10): A0A2U3TZJ2, B7Z3M0, Q6PEZ8, K7EJ07, K7EMV0, K7EPI2, K7EPR1, K7ER84, K7ERE6, K7ESB1

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Secreted. Extracellular space. Extracellular matrix.

Post-translational modifications. N-glycosylated.

Similarity. Belongs to the small leucine-rich proteoglycan (SLRP) family. SLRP class V subfamily.

Isoforms (4)

UniProt IDNamesCanonical?
Q6PEZ8-11yes
Q6PEZ8-22
Q6PEZ8-33
Q6PEZ8-44

RefSeq proteins (5): NP_001139726, NP_001139727, NP_001357024, NP_001398066, NP_079101 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001611Leu-rich_rptRepeat
IPR003591Leu-rich_rpt_typical-subtypRepeat
IPR032675LRR_dom_sfHomologous_superfamily
IPR050333SLRPFamily

Pfam: PF13855

UniProt features (28 total): repeat 17, splice variant 3, sequence conflict 3, signal peptide 1, chain 1, domain 1, glycosylation site 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6PEZ8-F187.240.82

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (1): 64

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 50 (showing top): GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT, NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, chr19p13, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, MIKKELSEN_IPS_LCP_WITH_H3K4ME3, VDR_Q6, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, KRAS.AMP.LUNG_UP.V1_DN, KRAS.300_UP.V1_DN, KRAS.600_UP.V1_DN, GOCC_EXTERNAL_ENCAPSULATING_STRUCTURE, CDC5L_TARGET_GENES, GLI1_TARGET_GENES, ID1_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (2): extracellular matrix structural constituent (GO:0005201), protein binding (GO:0005515)

GO Cellular Component (3): obsolete extracellular space (GO:0005615), extracellular matrix (GO:0031012), extracellular region (GO:0005576)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
structural molecule activity1
extracellular matrix1
binding1
external encapsulating structure1
cellular anatomical structure1

Protein interactions and networks

STRING

658 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
PODNL1C19orf67A6NJJ6474
PODNL1LGALS1P09382451
PODNL1ADAMTS4O75173446
PODNL1WRNQ14191407
PODNL1PRKCGP05129406
PODNL1FREM3P0C091356
PODNL1NYXQ9GZU5354
PODNL1C19orf53Q9UNZ5349
PODNL1CTHRC1Q96CG8328
PODNL1RHBGQ9H310327
PODNL1DCAF4L1Q3SXM0325
PODNL1LRR1Q96L50318
PODNL1EPYCQ99645314
PODNL1TMED8Q6PL24305
PODNL1YJU2BP13994301

IntAct

8 interactions, top by confidence:

ABTypeScore
CRPQSOX1psi-mi:“MI:0914”(association)0.530
ZNRD2CCDC85Cpsi-mi:“MI:0914”(association)0.530
YWHAQPLEKHG3psi-mi:“MI:0914”(association)0.480
BBS7CDK4psi-mi:“MI:0914”(association)0.350
FTLpsi-mi:“MI:0914”(association)0.350
PCDH20CAPN5psi-mi:“MI:0914”(association)0.350
PYCR3ARHGAP32psi-mi:“MI:0914”(association)0.350

BioGRID (2): PODNL1 (Affinity Capture-MS), PODNL1 (Affinity Capture-MS)

ESM2 similar proteins: A2VDH3, A6H793, B0BNK7, D2HFT7, D4ABX8, E9Q7T7, O75325, P22792, P40197, Q13641, Q149C3, Q1RMS4, Q2EEY0, Q2I0M4, Q3UVD5, Q3UY51, Q4KLL3, Q4R8Y9, Q50LG9, Q5I2M7, Q5I2M8, Q5PQV5, Q5VT99, Q6NUI6, Q6P3Y9, Q6PEZ8, Q6PJG9, Q6UY18, Q6ZSA7, Q7M6Z0, Q7TQ62, Q7Z5L7, Q80WD0, Q80WD1, Q80XU8, Q86UN2, Q86UN3, Q8BHA1, Q8BLY3, Q8K0S5

Diamond homologs: B1H134, B1H234, D3ZTV3, F1NUK7, G5EFX6, G5EG78, O43155, O88280, P19879, P20774, P24014, P58874, P79119, P83286, Q5R6T0, Q5RAC4, Q5RBL2, Q62000, Q6PEZ8, Q6RKD8, Q70AK3, Q810C1, Q8BGT1, Q8BLU0, Q8MJF1, Q96PX8, Q9DE65, Q9NR97, Q9NZU0, Q9NZU1, Q9UBM4, Q9W6H0, O02678, O46378, O46379, O46390, O46403, P21809, P21810, P22792

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

130 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance120
Likely benign5
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1079 predictions. Top by Δscore:

VariantEffectΔscore
19:13933452:CTTG:Cacceptor_gain1.0000
19:13933453:TTG:Tacceptor_gain1.0000
19:13933454:TG:Tacceptor_gain1.0000
19:13933456:C:CCacceptor_gain1.0000
19:13933456:C:CGacceptor_loss1.0000
19:13933457:T:Aacceptor_loss1.0000
19:13933872:CTGTA:Cdonor_loss1.0000
19:13933873:TGTA:Tdonor_loss1.0000
19:13933875:TA:Tdonor_loss1.0000
19:13933876:A:ACdonor_gain1.0000
19:13933876:A:Cdonor_loss1.0000
19:13933877:C:CCdonor_gain1.0000
19:13933989:TTGTT:Tacceptor_gain1.0000
19:13933990:TGTT:Tacceptor_gain1.0000
19:13933991:GTT:Gacceptor_gain1.0000
19:13933992:TT:Tacceptor_gain1.0000
19:13933994:C:CCacceptor_gain1.0000
19:13933994:C:CGacceptor_loss1.0000
19:13933995:T:Aacceptor_loss1.0000
19:13934241:A:ACdonor_gain1.0000
19:13934242:C:CCdonor_gain1.0000
19:13936363:TCA:Tdonor_loss1.0000
19:13936364:CACCT:Cdonor_loss1.0000
19:13936366:C:CTdonor_loss1.0000
19:13937781:CCACC:Cdonor_loss1.0000
19:13937782:CACCT:Cdonor_loss1.0000
19:13937783:ACCTG:Adonor_loss1.0000
19:13937784:C:CTdonor_loss1.0000
19:13952640:TCA:Tdonor_gain1.0000
19:13952640:TCAAG:Tdonor_loss1.0000

AlphaMissense

3645 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000035776 (19:13931315 C>T), RS1000040102 (19:13941248 C>T), RS1000111425 (19:13954049 G>A), RS1000279383 (19:13942143 T>C,G), RS1000880519 (19:13949252 G>A), RS1000983558 (19:13942874 A>G), RS1001041808 (19:13954541 C>G,T), RS1001097555 (19:13949071 T>C,G), RS1001168382 (19:13943594 T>C), RS1001214925 (19:13940356 G>A), RS1001282199 (19:13946749 G>A), RS1001313566 (19:13946933 C>A), RS1001473587 (19:13953469 T>G), RS1001660093 (19:13953913 G>A), RS1001839602 (19:13953255 C>G,T)

Disease associations

OMIM: gene MIM:621043 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

20 total (human), top 20 by PubMed support.

ChemicalActions (top 5)PubMed papers
Particulate Matterdecreases expression, increases abundance2
propionaldehydeincreases expression1
deoxynivalenoldecreases expression1
ethyl-p-hydroxybenzoatedecreases expression1
sodium arseniteincreases expression1
nutlin 3affects cotreatment, increases expression1
licochalcone Bincreases expression1
Dasatinibincreases expression1
Resveratrolaffects cotreatment, decreases expression1
Air Pollutantsincreases abundance, decreases expression1
Atrazineincreases expression1
Benzo(a)pyreneaffects methylation1
Camptothecinincreases expression1
Dactinomycinaffects cotreatment, increases expression1
Estradiolaffects cotreatment, increases expression1
Plant Extractsaffects cotreatment, decreases expression1
Tobacco Smoke Pollutiondecreases expression1
Valproic Acidincreases methylation1
Okadaic Aciddecreases expression1
Lactic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.